The clinical study was based on the outcomes to demonstrate the relationship between TRD and inflammation in human models of depression by measuring inflammatory biomarkers CRP, Interleukin-6 (IL-6) and TNF-α and stress markers (corticosterone). This evidence concerns the gene IL6 and depressive symptom measurement.